Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish CohortRamón Teira, Adrián Curran, Alberto Romero-Palacios et al.|Infectious Diseases and Therapy|2022Cited by 6
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohortRamón Teira, Núria Espinosa, Helena Díaz-Cuervo et al.|HIV Research & Clinical Practice|2021Cited by 3